Evidence map›Paper›PMID 27378367›Full record

ArticleJournal of travel medicine2016

A comparison of compliance rates with anti-vectorial protective measures during travel to regions with dengue or chikungunya activity, and regions endemic for Plasmodium falciparum malaria.

Tahaniyat Lalani, Heather Yun, David Tribble, Anuradha Ganesan, Anjali Kunz, Mary Fairchok, Elizabeth Schnaubelt, Jamie Fraser, Indrani Mitra, Karl C Kronmann and 4 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of travel medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05203744 (Safety, Tolerability and Pharmacokinetics of Tafenoquine After Weekly and Escalating Monthly Doses of Tafenoquine in Healthy Vietnamese Volunteers), which is not on this map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05203744 phase4unknown statusnot on this mapstarted 2022, after this paper: background citation

Safety, Tolerability and Pharmacokinetics of Tafenoquine After Weekly and Escalating Monthly Doses of Tafenoquine in Healthy Vietnamese Volunteers

TypeinterventionalSponsorNaval Medical Research CenterRan2022 to 2022Enrolled200ConditionsProphylaxisArmsTafenoquine prophylaxis
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Rapid diagnostic tests for determining dengue serostatus: a systematic review and key informant interviews.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2019
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. The Burden of Arboviral Infections in the Military Health System 2012-2019.The American journal of tropical medicine and hygiene · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Dengue: A Minireview.Viruses · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Yellow Fever in Travelers.Current infectious disease reports · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 2 countries.

Tahaniyat LalaniDepartment of Preventive Medicine and Biostatistics, Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Heather YunSan Antonio Uniformed Services Health Education, Fort Sam Houston, TX, USA.
David TribbleDepartment of Preventive Medicine and Biostatistics, Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Anuradha GanesanDepartment of Preventive Medicine and Biostatistics, Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Anjali KunzMadigan Army Medical Center, Tacoma, WA, USA.
Mary FairchokDepartment of Preventive Medicine and Biostatistics, Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Elizabeth SchnaubeltLandstuhl Regional Medical Center, Landstuhl, Germany.
Jamie FraserDepartment of Preventive Medicine and Biostatistics, Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Indrani MitraDepartment of Preventive Medicine and Biostatistics, Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Karl C KronmannDivision of Infectious Diseases, Naval Medical Center Portsmouth, Portsmouth, VA, USA.
Timothy BurgessSan Antonio Uniformed Services Health Education, Fort Sam Houston, TX, USA.
Robert G DeissDepartment of Preventive Medicine and Biostatistics, Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Mark S RiddleEnteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, USA.
Mark D JohnsonNaval Medical Center of San Diego, San Diego, CA, USA.
Uniformed Services University of the Health Sciences · USMadigan Army Medical Center · USSan Antonio Uniformed Services Health Education Consortium · USLandstuhl Regional Medical Center · DENaval Health Research Center · USNaval Medical Center Portsmouth · USNaval Medical Center San Diego · USNaval Medical Research Command · USWalter Reed National Military Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is limited information on compliance rates with anti-vectorial protective measures (AVPMs) during travel to countries with risk of dengue and chikungunya. We evaluated differences in mosquito exposures, and factors associated with AVPM compliance in travellers going to countries where the principal mosquito-borne infectious disease threat is falciparum malaria and those where risk of dengue or chikungunya predominates.

methodsDepartment of Defence beneficiaries with planned travel to regions where the predominant mosquito-borne infection is falciparum malaria, and those with predominantly dengue or chikungunya risk, were included. Regions were divided into three groups: 'high-risk falciparum malaria', 'low-risk falciparum malaria' and 'chikungunya/dengue risk'. Demographics, trip characteristics, arthropod exposure and AVPM compliance were captured using pre- and post-travel surveys. Skin repellent compliance was defined as self-reported use, categorized as 'often/every day'. A logistic regression model was used to estimate factors associated with AVPM compliance.

results183 (9%), 185 (9%) and 149 (7%) travelled to high and low falciparum malaria risk regions, and chikungunya/dengue risk regions, respectively. Overall, 53% (95% CI: 48-57%) and 16% (95% CI: 12-19%) were compliant with repellent use on skin and clothing, respectively. Daytime bites were reported more frequently in chikungunya/dengue risk regions than high malaria risk regions (37% vs. 10%), while night time bites were frequently in high malaria risk regions (53% vs 20%; P < 0.001). Compliance with skin repellents was associated with female gender [RR: 1.54 (95% CI: 1.05-2.28)], observing mosquitoes during travel [RR: 2.77 (95% CI: 1.76-4.36)] and travel during the rainy season [RR: 2.45 (95% CI: 1.66-3.71)]).

conclusionsPoor AVPM compliance was observed in the overall cohort. Compliance with skin repellent use was associated with female gender, observing mosquitoes and travelling during the rainy season, and was not associated with the risk of malaria or chikungunya/dengue at the travel destination.

Indexed as

TravelAntimalarialsChemopreventionChikungunya FeverDengueFemaleHumansInsect Bites and StingsInsect RepellentsMalaria, FalciparumMalePatient ComplianceTropical MedicineAntimalarialsInsect RepellentsAnti-vectorial protective measureschikungunyacompliancedenguemalaria

Identifiers

PMID27378367
PMCPMC4939934
OpenAlexW2474641988

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.